Despite growing evidence on the therapeutic potential of flavonoids, the mechanistic understanding of how these compounds modulate key PCOS-related pathways, particularly the adipokine–cytokine network, insulin signaling, and ovarian dysfunction, remain fragmented. Here, INS is linked to polycystic ovary syndrome.